Mikhail Bakhman is the founder of PANDENOMIKA, a company that specializes in the development of new technologies for the treatment of infectious diseases. He has over 20 years of experience in the field of infectious diseases and has been involved in the development of new treatments for HIV, hepatitis C, and tuberculosis. He has also worked on the development of new vaccines for influenza and other infectious diseases. In addition to his work at PANDENOMIKA, Mikhail Bakhman is also a professor at the MoscoMore...